Spruce Biosciences, Inc.

NASDAQ:SPRB

Biotechnology

Healthcare
$40.49 +5.07%

+$2.47 today

Market cap
$116.37M
Beta
3.20
P/E (TTM)
-1.9
EPS (TTM)
-$27.11
52W Low $7.00High $838.13

Volume 0.05M

Average 0.06M

Balance Sheet

Inspect the capital base behind the business.

Assets

$53.02M

FY 2025 · Annual

+17.3% YoY

Liabilities

$10.51M

FY 2025 · Annual

-35.9% YoY

Equity

$42.52M

FY 2025 · Annual

+47.5% YoY

Balance Sheet

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Cash & Equivalents42.75M24.49M96.34M38.75M48.91M
Short-term Investments46.22M54.59M000
Net Receivables00000
Inventory00000
Other Current Assets396K1.21M1.97M2.28M2.85M
Total Current Assets91.9M83.61M102.18M44.21M52.11M
Property, Plant & Equipment (Net)1.48M1.4M1.18M934K666K
Goodwill00000
Intangible Assets00000
Long-term Investments32.46M(54.54M)0036K
Tax Assets00000
Other Non-current Assets653K55.18M582K69K207K
Total Non-current Assets34.59M2.04M1.76M1M909K
Total Assets126.49M85.65M103.95M45.21M53.02M
Account Payables2.82M1.43M3.33M1.3M943K
Short-term Debt01.62M1.62M1.62M0
Tax Payables00000
Deferred Revenue004.91M00
Other Current Liabilities1.44M1.29M11.25M882K1.77M
Total Current Liabilities8.87M12.45M24.47M15.25M10.09M
Long-term Debt4.88M3.29M1.72M124K419K
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities73K161K236K282K0
Total Non-current Liabilities6.24M4.72M2.97M1.14M419K
Total Liabilities15.12M17.16M27.44M16.39M10.51M
Common Stock3K3K4K4K0
Retained Earnings(103.13M)(149.31M)(197.23M)(250.27M)(289.23M)
Accumulated OCI(184K)(558K)000
Other Stockholders Equity00000
Minority Interest00000
Total Equity111.37M68.49M76.51M28.82M42.52M
Total Debt6.53M6.32M4.61M2.77M736K
Net Debt(36.22M)(18.17M)(91.73M)(35.99M)(48.17M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$54.1M
Other Current$952.0K
Total Current Assets$55.0M
PP&E (Net)$595.0K
Long-term Investments$36.0K
Other Non-current$503.0K
Total Non-current Assets$1.1M
Total Assets$56.2M

Analysis

Selected assets total $56.2M for Latest. The largest visible component is Cash & Equivalents at $54.1M, about 96.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 9, 2026
SC 13GSC 13G filingAug 14, 2026
SC 13G/ASC 13G/A filingAug 14, 2026
SC 13GSC 13G filingAug 14, 2026

How much cash does SPRB have?

Spruce Biosciences, Inc. (SPRB) reported $48.91M in cash and equivalents in fiscal 2025.

How much debt does SPRB carry?

Spruce Biosciences, Inc. (SPRB) reported $736,000.00 of total debt, with net debt of -$48.17M.